Chika Ogami

Chika Ogami

Auto-generated profile, based on publicly available information

Chika Ogami

Department of Medical Pharmaceutics, School of Pharmacy and Pharmaceutical Sciences University of Toyama Toyama Toyama Japan

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Internal Medicine
Verified
Journal Article
Open access
YHYoshitsugu Higashi
Yoshitsugu Higashi
SNShigeki Nakamura
Shigeki Nakamura
YTYasuhiro Tsuji
Yasuhiro Tsuji
COChika Ogami
Chika Ogami
KMKaoru Matsumoto
Kaoru Matsumoto
YYYoshihiro Yamamoto
Yoshihiro Yamamoto
A 53-year-old man was admitted to the hospital with a diagnosis of cellulitis and osteomyelitis. Twenty-four days after the initiation of daptomycin and sulbactam/ampicillin, he developed a fever and pulmonary infiltration. Bronchoalveolar lavage revealed a high number of eosinophils, while an intracutaneous test revealed positivity for daptomycin. The patient improved after discontinuing antimicrobial therapy. The plasma daptomycin minimum concentration (Cmin) was elevated (27.4 μg/mL), but plasma protein binding of daptomycin was low (87.8%). Although the pathophysiology of eosinophilic pneumonia remains unclear, antigenic stimulation due to daptomycin accumulation in the alveoli may have caused continuous immune activation.

10 December 2021 in Medicine
Verified
Journal Article
Open access
YTYasuhiro Tsuji
Yasuhiro Tsuji
MNMiki Numajiri
Miki Numajiri
COChika Ogami
Chika Ogami
FKFumihiro Kurosaki
Fumihiro Kurosaki
AMAoi Miyamoto
Aoi Miyamoto
YYYoshihiro Yamamoto
Yoshihiro Yamamoto
The objective of the present study was to develop a method to measure tedizolid (TZD) concentration for studying target concentration intervention, pharmacokinetics, and pharmacodynamics of TZD. We established a high-performance liquid chromatography-fluorescence detector assay to measure the TZD concentration in serum for clinical application. Chromatographic separation was carried out on a 5 μm octadecyl silane hypersil column 150 mm × 4.6 mm. The mobile phase consisted of 0.1 M phosphoric acid and methanol (60:40, pH 7.0). Detection was performed at 300 nm and 340 nm for the excitation and emission wavelengths, respectively. The average retention times of TZD and the internal standard were 12.9 and 8.8 min, respectively. High linearity was exhibited over a concentration range of 0.025 to 10.0 μg/mL for TZD (R 2 > 0.999). The intra- and inter-assay accuracies of TZD were 99.2% to 107.0% and 99.2% to 107.7%, respectively. The lower limit of quantitation and the lower limit of detection for TZD measurement were 0.025 and 0.01 μg/mL, respectively. The extraction recoveries of TZD were 100.4% to 114.1%. The high-performance liquid chromatography method developed in this study could separate the analytes with a single eluent (isocratic system), within a total run time of 15 min. Both TZD and IS were well separated, without interference from the peaks. Sharp peaks were observed in the chromatograms; problems such as double peaks, shoulder peaks, and broadened peaks were not observed. The proposed method showed acceptable analytical performance and could be used to evaluate serum TZD concentrations in patients.

7 December 2018 in European Journal of Drug Metabolism and Pharmacokinetics
Verified
Journal Article
Closed access
PDF file
DYDaichi Yamaguchi
Daichi Yamaguchi
YTYasuhiro Tsuji
Yasuhiro Tsuji
MSMiki Sonoda
Miki Sonoda
KSKenji Shin
Kenji Shin
HKHiroko Kito
Hiroko Kito
HKHidetoshi Kamimura
Hidetoshi Kamimura

4 December 2024 in Clinical and Translational Science
Verified
Journal Article
Open access
YSYuki Suzuki
Yuki Suzuki
NMNoriko Matsunaga
Noriko Matsunaga
TATakahiko AOYAMA
Takahiko AOYAMA
COChika Ogami
Chika Ogami
CHChihiro Hasegawa
Chihiro Hasegawa
YTYasuhiro Tsuji
Yasuhiro Tsuji
The pharmacokinetics (PKs) of mycophenolic acid (MPA) exhibit considerable complexity and large variability. We developed a population pharmacokinetic (popPK) model to predict the complex PK of MPA by examining an absorption model. Forty‐two patients who had undergone renal transplantation were included in this study. popPK analysis, incorporating several absorption models, was performed using the nonlinear mixed‐effects modeling program NONMEM. The MPA area under the concentration‐time curve at 0–12 h (AUC0–12) was simulated using the final model to calculate the recommended dose. The PK of MPA was adequately described using a two‐compartment model incorporating sequential zero‐ and first‐order absorption with lag time. Total body weight, renal function (RF), and posttransplantation day (PTD) were included as covariates affecting MPA PK. The final model estimates were 7.56, 11.6 L/h, 104.0 L, 17.3 L/h, 169.0 L, 0.0453, 0.283, and 1.95 h for apparent nonrenal clearance, apparent renal clearance, apparent central volume of distribution, apparent intercompartmental clearance, apparent peripheral volume of distribution, absorption half‐life, lag time, and duration of zero‐order absorption, respectively. Simulation results showed that a dose regimen of 500–1000 mg twice daily is recommended during the early posttransplantation period. However, dose reduction could be required with increased PTD and decreased RF. The complex PK of MPA was explained using an absorption model. The developed popPK model can provide useful information regarding individual dosing regimens based on PTD and RF.

2 March 2023 in European Journal of Drug Metabolism and Pharmacokinetics
Verified
Journal Article
Closed access
PDF file
STSaki Takahashi
Saki Takahashi
YTYasuhiro Tsuji
Yasuhiro Tsuji
NHNick Holford
Nick Holford
COChika Ogami
Chika Ogami
HKHidefumi Kasai
Hidefumi Kasai
YYYoshihiro Yamamoto
Yoshihiro Yamamoto

20 October 2023 in Annals of Oncology
Verified
Journal Article
Closed access
YKY. Kuboki
Y. Kuboki
SKS. Kitano
S. Kitano
MIMasafumi Ikeda
Masafumi Ikeda
TKTakafumi Koyama
Takafumi Koyama
HMH. Mizugaki
H. Mizugaki
NYN. Yamamoto
N. Yamamoto